Valneva SE (VALN) Shares Outstanding (Weighted Average) (2020 - 2026)

Valneva SE's (VALN) quarterly Shares Outstanding (Weighted Average) came in at $30.5 million in Q1 2026, up 19.08% year-on-year from $25.6 million in Q1 2025, and up 0.77% quarter-over-quarter from $30.3 million in Q4 2025.

Valneva SE (VALN) Shares Outstanding (Weighted Average) (2020 - 2026) Analysis & Trends

Valneva SE has disclosed Shares Outstanding (Weighted Average) across 7 years of filings, most recently posting $30.5 million for Q1 2026.

  • Shares Outstanding (Weighted Average) for Q1 2026 came in at $30.5 million, up 19.08% year-over-year; the trailing twelve-month figure through Mar 2026 was $30.5 million (up 19.08% YoY), and the FY2025 annual result was $30.3 million, down 82.54% from the prior year.
  • Shares Outstanding (Weighted Average) came in at $30.5 million for Q1 2026 at Valneva SE, up from $30.3 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $173.5 million in Q4 2024 to a low of $269.36 in Q1 2022.
  • The 5-year median for Shares Outstanding (Weighted Average) is $25.6 million (2025), against an average of $45.2 million.
  • Across the five-year window, Shares Outstanding (Weighted Average) surged 8269094.54% in 2023 and slumped 82.54% in 2025, its largest moves.
  • Valneva SE's Shares Outstanding (Weighted Average) stood at $141.0 million in 2022, then increased by 5.87% to $149.3 million in 2023, then rose by 16.21% to $173.5 million in 2024, then plunged by 82.54% to $30.3 million in 2025, then advanced by 0.77% to $30.5 million in 2026.
  • The last three Shares Outstanding (Weighted Average) figures came in at $30.5 million (Q1 2026), $30.3 million (Q4 2025), and $30.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - 185,491.37 Bn
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - 400.00 Bn
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - 4,489.46 Bn
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 100.00 Bn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - 118.76 Bn
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - 417.01 Bn
7 Psyence Biomedical 241.78 Bn 241.78 Bn - 68.88 Bn
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 254.10 Mn
9 Abivax 94.26 Bn 94.26 Bn - 928.40 Mn
10 Valneva SE 167.33 Mn 44.10 Mn 5.08 Mn 30.54 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 30.54 Mn
Dec 31, 2025 30.30 Mn
Sep 30, 2025 30.14 Mn
Jun 30, 2025 28.90 Mn
Mar 31, 2025 25.64 Mn
Dec 31, 2024 173.54 Mn
Sep 30, 2024 26.73 Mn
Jun 30, 2024 22.50 Mn
Mar 31, 2024 22.70 Mn
Dec 31, 2023 149.33 Mn
Sep 30, 2023 22.68 Mn
Jun 30, 2023 22.69 Mn
Mar 31, 2023 22.27 Mn
Dec 31, 2022 141.04 Mn
Sep 30, 2022 927.61
Jun 30, 2022 18.78 Mn
Mar 31, 2022 269.36
Dec 31, 2021 120.25 Mn
Sep 30, 2021 2,960.01
Dec 31, 2020 108.46 Mn